Race against time: drug trial aims to halt sudden blindness

NCT ID NCT04526951

Summary

This study tested if a fast-acting clot-busting drug could save vision in people who suddenly lose sight due to a blocked artery in the eye. 81 patients were randomly assigned to receive either the drug (tenecteplase) or aspirin within 4.5 hours of symptoms starting. The main goal was to see if the drug led to significantly better vision recovery one month later.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL RETINAL ARTERY OCCLUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aarhus University Hospital

    Aarhus, Denmark

  • Bispebjerg University Hospital

    Copenhagen, Denmark

  • Haukeland University Hospital

    Bergen, Norway

  • Helse Nord Trøndelag Trust

    Namsos, Norway

  • Helsinki University Hospital

    Helsinki, Finland

  • Karolinska University Hospital

    Stockholm, Sweden

  • Kauno Klinikos Kaunas

    Kaunas, Lithuania

  • Oslo University Hospital

    Oslo, 0424, Norway

  • Rigshospitalet University Hospital

    Copenhagen, Denmark

  • St Olav University Hospital

    Trondheim, Norway

  • Telemark Hospital Trust

    Skien, Norway

  • Turku University Hospital

    Turku, Finland

  • University Hospital Antwerp

    Antwerp, Belgium

  • University Hospital Leuven

    Leuven, 3000, Belgium

  • Vestfold Hospital Trust

    Tønsberg, Norway

  • Vestre Viken Hospital Trust Drammen

    Drammen, Norway

  • Vilnius University Hospital

    Vilnius, Lithuania

  • Østfold Hospital Trust Kalnes, Dept of Ophthalmology

    Grålum, Norway

Conditions

Explore the condition pages connected to this study.